Circadian Disruption as a Driver of Carcinogenesis: Advances in Mechanistic Understanding
DOI:
https://doi.org/10.61173/xghg2k98Keywords:
Circadian rhythm, Cancer; Metabolism, Melatonin, ChronotherapyAbstract
The circadian rhythm of organisms is regulated by the biological clock, a regular circadian rhythm is crucial for the physiological balance of the body and has an inhibitory effect on the development of many diseases, especially cancer. The relationship between circadian rhythm and cancer includes cell cycle regulation, hormone level changes, immune and inflammatory responses, as well as metabolic and oxidative stress regulation, indicating that maintaining a regular circadian rhythm is of great significance in preventing and treating cancer diseases. This article discusses the intricate relationship between circadian rhythm and cancer, and explores the way that circadian rhythm disorders are involved in tumorigenesis mechanisms and promote cancer progression. Maintaining a healthy circadian rhythm cycle includes avoiding exogenous factors (shift work, jet lag, artificial lighting, irregular sleep patterns) and early detection of endogenous factores (genetic factors). Mutations in clock control genes and epigenetics can promote tumor growth and also affect the efficacy of therapeutic drugs, leading to the need to regulate circadian rhythms and specific timing of administration to enhance the drug efficacy. The growth of tumors is mainly stimulated by DNA damage and decompensation of tumor suppressor genes, and then developed through immune and inflammatory responses, which are closely related to the components of the biological clock. At present, chronotherapy has been continuously explored and experimented as a highly promising cancer treatment method, and may be applied in clinical practice in the future.
References
[1] Munteanu C, Turti S, Achim L, et al. The Relationship between Circadian Rhythm and Cancer Disease. Int J Mol Sci. 2024;25(11):5846.
[2] Amiama-Roig A, Verdugo-Sivianes EM, Carnero A, Blanco JR. Chronotherapy: Circadian Rhythms and Their Influence in Cancer Therapy. Cancers (Basel). 2022;14(20):5071.
[3] Li H, Li M, Chen K, Li Y, Yang Z, Zhou Z. The circadian clock gene ARNTL overexpression suppresses oral cancer progression by inducing apoptosis via activating autophagy. Med Oncol. 2022;39(12):244.
[4] Pariollaud M, Lamia KA. Cancer in the Fourth Dimension: What Is the Impact of Circadian Disruption. Cancer Discov. 2020;10(10):1455-1464.
[5] Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev. 2013;17(4):273-284.
[6] Sang D, Lin K, Yang Y, et al. Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals. Cell. 2023;186(25):5500-5516.e21.
[7] De Lorenzo BHP, Novaes E Brito RR, Paslar Leal T, et al. Chronic Sleep Restriction Impairs the Antitumor Immune Response in Mice. Neuroimmunomodulation. 2018;25(2):59-67.
[8] Huang J, Song P, Hang K, et al. Sleep Deprivation Disturbs Immune Surveillance and Promotes the Progression of Hepatocellular Carcinoma. Front Immunol. 2021; 12:727959.
[9] Vaghari-Tabari M, Ferns GA, Qujeq D, Andevari AN, Sabahi Z, Moein S. Signaling, metabolism, and cancer: An important relationship for therapeutic intervention. J Cell Physiol. 2021;236(8):5512-5532.
[10] Kartikasari AER, Huertas CS, Mitchell A, Plebanski M. Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis. Front Oncol. 2021; 11:692142.
[11] Al-Abri MA, Al-Yaarubi S, Said EA. Circadian Rhythm, Sleep, and Immune Response and the Fight against COVID-19. Oman Med J. 2023;38(2): e477.
[12] Dimitrov S, Lange T, Fehm HL, Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun. 2004;18(4):368- 374.
[13] Zhou L, Zhang Z, Nice E, Huang C, Zhang W, Tang Y. Circadian rhythms and cancers: the intrinsic links and therapeutic potentials. J Hematol Oncol. 2022;15(1):21.
[14] Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab. 2018;62(4):472-479.
[15] Gnocchi D, Bruscalupi G. Circadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications. Biology (Basel). 2017;6(1):10.
[16] Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93(20):1557-1562.
[17] Flynn-Evans EE, Mucci L, Stevens RG, Lockley SW. Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst. 2013;105(17):1292-1297.
[18] Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007;67(21):10618-10622.
[19] Lahti TA, Partonen T, Kyyrönen P, Kauppinen T, Pukkala E. Night-time work predisposes to non-Hodgkin lymphoma. Int J Cancer. 2008;123(9):2148-2151.
[20] Pukkala E, Aspholm R, Auvinen A, et al. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ. 2002;325(7364):567.
[21] Rafnsson V, Hrafnkelsson J, Tulinius H. Incidence of cancer among commercial airline pilots. Occup Environ Med. 2000;57(3):175-179.
[22] Gudmundsdottir EM, Hrafnkelsson J, Rafnsson V. Incidence of cancer among licenced commercial pilots flying North Atlantic routes. Environ Health. 2017;16(1):86.
[23] McNeely E, Mordukhovich I, Staffa S, Tideman S, Gale S, Coull B. Cancer prevalence among flight attendants compared to the general population. Environ Health. 2018;17(1):49.
[24] Buja A, Mastrangelo G, Perissinotto E, et al. Cancer incidence among female flight attendants: a meta-analysis of published data. J Womens Health (Larchmt). 2006;15(1):98-105.
[25] Zee PC, Attarian H, Videnovic A. Circadian rhythm abnormalities. Continuum (Minneap Minn). 2013;19(1 sleep disorders):132-147.
[26] Patke A, Murphy PJ, Onat OE, et al. Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase Disorder. Cell. 2017;169(2):203-215.e13.
[27] Milagro FI, Gómez-Abellán P, Campión J, Martínez JA, Ordovás JM, Garaulet M. CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int. 2012;29(9):1180-1194.
[28] Lamia KA, Sachdeva UM, DiTacchio L, et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science. 2009;326(5951):437-440.
[29] Lowrey PL, Shimomura K, Antoch MP, et al. Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science. 2000;288(5465):483-492.
[30] Peng H, Zhu Y, Goldberg J, Vaccarino V, Zhao J. DNA Methylation of Five Core Circadian Genes Jointly Contributes to Glucose Metabolism: A Gene-Set Analysis in Monozygotic Twins. Front Genet. 2019; 10:329.
[31] Oishi Y, Hayashi S, Isagawa T, et al. Bmal1 regulates inflammatory responses in macrophages by modulating enhancer RNA transcription. Sci Rep. 2017;7(1):7086. Published 2017 Dean&Francis ISSN 2959-409X Aug 1.
[32] Hudec M, Dankova P, Solc R, Bettazova N, Cerna M. Epigenetic Regulation of Circadian Rhythm and Its Possible Role in Diabetes Mellitus. Int J Mol Sci. 2020;21(8):3005.
[33] Shafi AA, Knudsen KE. Cancer and the Circadian Clock. Cancer Res. 2019;79(15):3806-3814.
[34] Jiang W, Zhao S, Jiang X, et al. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Cancer Lett. 2016;371(2):314-325.
[35] Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302(5643):255- 259.
[36] Liu H, Liu Y, Hai R, Liao W, Luo X. The role of circadian clocks in cancer: Mechanisms and clinical implications. Genes Dis. 2022;10(4):1279-1290. Published 2022 May 28.
[37] Yu H, Meng X, Wu J, et al. Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One. 2013;8(4): e61679.
[38] Ye Y, Xiang Y, Ozguc FM, et al. The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy. Cell Syst. 2018;6(3):314-328.e2.
[39] Cadenas C, van de Sandt L, Edlund K, et al. Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014;13(20):3282- 3291.
[40] Mannic T, Meyer P, Triponez F, et al. Circadian clock characteristics are altered in human thyroid malignant nodules. J Clin Endocrinol Metab. 2013;98(11):4446-4456.
[41] Hoffman AE, Zheng T, Ba Y, et al. Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways. BMC Cancer. 2010; 10:110.
[42] Chen Z, McKnight SL. A conserved DNA damage response pathway responsible for coupling the cell division cycle to the circadian and metabolic cycles. Cell Cycle. 2007;6(23):2906- 2912.
[43] Arble DM, Bass J, Behn CD, et al. Impact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop Discussions. Sleep. 2015;38(12):1849- 1860.
[44] Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019; 92:121-135.
[45] Redwine L, Hauger RL, Gillin JC, Irwin M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab. 2000;85(10):3597-3603.
[46] Chen B, Li H, Zeng X, et al. Roles of microRNA on cancer cell metabolism. J Transl Med. 2012; 10:228.
[47] Rottiers V, Näär AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13(4):239- 250.
[48] Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85-95.
[49] Ahmad A, Aboukameel A, Kong D, et al. Phosphoglucose isomerase/autocrine motility factor mediates epithelialmesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res. 2011;71(9):3400-3409.
[50] Cannistraci A, Hascoet P, Ali A, et al. MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer. Oncogene. 2022;41(10):1445-1455.
[51] Eichner LJ, Perry MC, Dufour CR, et al. miR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1β/ ERRγ transcriptional pathway. Cell Metab. 2010;12(4):352-361.
[52] Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol. 2011;164(6):899-904.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
